Ulrich Kosciessa - Ceapro Director

CRPOF Stock  USD 0.19  0.00  0.00%   

Director

Dr. Ulrich Kosciessa is the Director of Ceapro Inc since 2015.
Tenure 9 years
Professional MarksPh.D
Phone780 421 4555
Webhttps://www.ceapro.com
Kosciessa has over two decades of research, business development and marketing leadership experience. He is a member of the Executive Management Board of Medac GmbH, a global pharmaceutical company with operations in 70 countries, Managing Director of Medac International, and Chairman of the Board of Medac Pharma Inc., a U.S.based subsidiary of Medac GmbH focused on specialty pharmaceuticals for autoimmune diseases and cancer. In addition, since 2006 Dr. Kosciessa has also served as Chief Executive Officer of Photonamic, a subsidiary of Medac GmbH focused on research and development of photodynamic therapy and diagnostics. He has successfully developed two Photonamic products currently marketed in Europe, South America and the AsianPacific region plus Australia. From 2006 to 2008, Dr. Kosciessa also served as Chief Executive Officer at Immune Laboratory of Hannover, a researchbased organization focused on autologous dendritic cellbased tumor vaccines. Prior to joining Medac GmbH, Dr

Ceapro Management Efficiency

The company has return on total asset (ROA) of 0.1124 % which means that it generated a profit of $0.1124 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1817 %, meaning that it generated $0.1817 on every $100 dollars invested by stockholders. Ceapro's management efficiency ratios could be used to measure how well Ceapro manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 2.51 M in total debt with debt to equity ratio (D/E) of 0.08, which may suggest the company is not taking enough advantage from borrowing. Ceapro Inc has a current ratio of 18.28, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Ceapro until it has trouble settling it off, either with new capital or with free cash flow. So, Ceapro's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ceapro Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ceapro to invest in growth at high rates of return. When we think about Ceapro's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Alexander HamiltonBarloworld Ltd ADR
68
Koshiro KudoAsahi Kaisei Corp
64
Jingbin GuoAnhui Conch Cement
58
Soichiro HashizumeAsahi Kaisei Corp
58
Hideyuki YamagishiAsahi Kaisei Corp
N/A
Dominic SewelaBarloworld Ltd ADR
51
Steven PfeifferBarloworld Ltd ADR
63
Yunyan ZhangAnhui Conch Cement
43
Donald WilsonBarloworld Ltd ADR
59
Michael FerraroAlumina Limited
N/A
Frances EdozienBarloworld Ltd ADR
51
Mingjing ZhangAnhui Conch Cement
53
Norio IchinoAsahi Kaisei Corp
75
Kenji HamaiAsahi Kaisei Corp
N/A
Daguang LiangAnhui Conch Cement
57
Ryujiro YoshinoAsahi Kaisei Corp
N/A
Alexander LandiaBarloworld Ltd ADR
50
Mianzhi YangAnhui Conch Cement
48
Babalwa NgonyamaBarloworld Ltd ADR
40
Emma SteinAlumina Limited
55
Kenyu AdachiAsahi Kaisei Corp
62
Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company was incorporated in 1997 and is headquartered in Edmonton, Canada. CEAPRO INC is traded on OTC Exchange in the United States. Ceapro Inc [CRPOF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Ceapro Inc Leadership Team

Elected by the shareholders, the Ceapro's board of directors comprises two types of representatives: Ceapro inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ceapro. The board's role is to monitor Ceapro's management team and ensure that shareholders' interests are well served. Ceapro's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ceapro's outside directors are responsible for providing unbiased perspectives on the board's policies.
Donald Oborowsky, Independent Director
Stacy Prefontaine, CFO, Corporate Secretary
William Li, Director
John Zupancic, Independent Director
Gilles Gagnon, President CEO, Director
ICDD MBA, Pres CEO
Ulrich Kosciessa, Director
Bernhard Seifried, Director Technology
Sigrun Watson, Chief Officer
Glenn Rourke, Independent Director

Ceapro Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Ceapro a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ceapro in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ceapro's short interest history, or implied volatility extrapolated from Ceapro options trading.

Pair Trading with Ceapro

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ceapro position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ceapro will appreciate offsetting losses from the drop in the long position's value.

Moving together with Ceapro OTC Stock

  0.88CHKEZ Chesapeake EnergyPairCorr
  0.92CHKEL Chesapeake EnergyPairCorr

Moving against Ceapro OTC Stock

  0.81TLK Telkom Indonesia Tbk Earnings Call This WeekPairCorr
  0.73ASTSW AST SpaceMobilePairCorr
  0.68TLKMF Telkom Indonesia TbkPairCorr
  0.66PTAIF PT Astra InternationalPairCorr
The ability to find closely correlated positions to Ceapro could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ceapro when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ceapro - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ceapro Inc to buy it.
The correlation of Ceapro is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ceapro moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ceapro Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ceapro can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ceapro Inc. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Complementary Tools for Ceapro OTC Stock analysis

When running Ceapro's price analysis, check to measure Ceapro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ceapro is operating at the current time. Most of Ceapro's value examination focuses on studying past and present price action to predict the probability of Ceapro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ceapro's price. Additionally, you may evaluate how the addition of Ceapro to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Stocks Directory
Find actively traded stocks across global markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Please note, there is a significant difference between Ceapro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ceapro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ceapro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.